TAO Synergies Inc TAOX

US Technology
$2.58 β–Ό -5.15% ($-0.14)
🎈 Low Float 📅 Earnings This Week
Open $2.68
Prev Close $2.72
Day Range $2.52 – $2.75
52W Range $2.17 – $8.77
Market Cap $21.88M
Beta 1.84
EPS (TTM) $-3.38

πŸ“‹ Company Profile

IndustryTechnology
CountryUS
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD
IPO Date2020-12-07
Shares Out.7,480,000
Websitesynaptogen.com/ β†—
Phone13026587581
Employees4
Revenue$88,626
Gross Profit$88,626
Net Income-$9.3M
Free Cash Flow-$6.2M
Total Assets$21.1M
Total Liabilities$3.8M
Equity$12.7M
About TAO Synergies Inc

TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.

TAO Synergies Inc is a publicly traded company under the ticker symbol TAOX on the NASDAQ NMS - GLOBAL MARKET, operating in the Technology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

πŸ“Š Analyst Ratings

7 analysts (2025-04-01)

Strong Buy 2
Buy 4
Hold 1

πŸ“° Latest News for TAOX

πŸ‘₯ Related Stocks